Perna canaliculus
Perna canaliculus has been studied in 1 paper since 2012: 1 trial in people. The newest paper, Jul 22, 2012: “Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles”.
1 paper studies it3 findingsUpdated
“We further confirm significant improvement (p < 0.05) in all OA outcome measures from T (0) to T (12) weeks for both the GLM and GS groups.”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
What did studies of Perna canaliculus find?
3Studies of Perna canaliculus measured 3 outcomes; the most studied are microbiome composition (1 study), Gastrointestinal Symptom Rating Scale (1) and knee osteoarthritis (1).
Microbiome composition
no changein humans1
1 study
Microbiome composition
no changein humans1
Perna canaliculus has no effect on microbiome composition in humans.
“There were no statistically significant changes in bacterial growth patterns determined by the Wilcoxon test.”
Human trialknee osteoarthritis12 weeks
Inflammopharmacology
Gastrointestinal Symptom Rating Scale
upin humans1
1 study
Gastrointestinal Symptom Rating Scale
upin humans1
Perna canaliculus improves Gastrointestinal Symptom Rating Scale in humans.
“The GSRS scores indicated that GIT function significantly improved over the 12 weeks duration with GLM and GS supplementation.”
Human trialknee osteoarthritiswhole GLM extract3,000 mg/day12 weeks
Inflammopharmacology
Knee osteoarthritis
downin humans1
1 study
Knee osteoarthritis
downin humans1
Perna canaliculus decreases knee osteoarthritis in humans (p < 0.05).
“We further confirm significant improvement (p < 0.05) in all OA outcome measures from T (0) to T (12) weeks for both the GLM and GS groups.”
Human trialknee osteoarthritiswhole GLM extract3,000 mg/day12 weeks
Inflammopharmacology